Description: The transition from academia to industry presents unique challenges and opportunities for medical device innovations. This session will provide an interactive forum for regulatory professionals, innovators, and technology transfer specialists to discuss the critical steps and best practices for successfully navigating the tech transfer journey. Participants will gain insights into regulatory considerations, intellectual property strategies, and funding opportunities that can accelerate the commercialization of early-stage innovations.
Attendees will benefit from real-world case studies and collaborative discussions focused on overcoming common hurdles, such as aligning academic research with industry standards, ensuring regulatory compliance from the outset, and engaging with stakeholders across the innovation ecosystem. The session will also explore strategies to bridge the gap between academic research timelines and industry expectations for commercialization.
By participating in this session, attendees will develop a deeper understanding of how to position early-stage technologies for successful industry adoption, mitigate regulatory risks early in the process, and create effective partnerships between academia and industry. This session is particularly valuable for professionals involved in regulatory affairs, technology transfer offices, startups, and academic research institutions seeking to bring their innovations to market.
Learning Objectives:
Upon completion, participants will be able to identify key regulatory considerations that should be addressed early in the technology transfer process to facilitate a smoother transition from academia to industry.
Upon completion, participants will be able to apply best practices for aligning academic research with industry expectations, regulatory requirements, and market demands to enhance the likelihood of successful product development.
Upon completion, participants will be able to outline strategies for protecting intellectual property and securing funding through effective licensing agreements and partnership models that align academic innovations with commercial goals.
.jpg "Frederike S. Brühschwein-Mandic photo")